Smolen Josef | Vienna General Hospital | The EULAR recommendation of RA treatment and clinical practice |
Joachim R. Kalden | Friedrich-Alexander University | Treat to Target -What does it mean for daily practice? |
Tore K Kvien | Diakonhjemmet Hospital, Oslo, Norway | What is the relevance of new ACR-EULAR diagnostic and remission criteria in RA for disease managemen |
栗占国 | 北京大学人民医院 | Functional analyses of the associated genes and the ethnic difference |
Pierre Miossec | Hospital Edouard Herriot in Lyon | IL-17 and contribution to rheumatoid arthritis chronicity |
Philip L. Cohen | Temple University School of Medicine | Targeting the B cell in Rheumatoid Arthritis: where do we go from here? |
Sylvain Bourgoin | Laval University | The autotoxin-lysophosphatidic acid (LPA) Axis in rheumatoid arthritis and LPA receptor functions |
James Louie | David Geffen School of Medicine,University of California, Los Angeles | Arthritis with RA in the 19th,20th and 21st centuries-Renoir, Dufy, and current artists |
Daniel Furst | UCLA Medical Center | Combination DMARDs: can they be used instead of Biologics in RA |
Foo Yew Liew | University of Glasgow | Novel cytokines and inflammatory Diseases |
栗占国 | 北京大学人民医院 | Our recent progress in genetics of RA |
Liwei Lv | 香港大学病理系 | Regulatory B cell and its implication in Autoimmunity |
Charles Mackay | Monash University | Develop new target therapies for inflammatory diseases including RA |
Robert J Moots | University of Liverpool | The role of neutrophils and relevant molecules in RA |
Di Yu | Monash University | Follicular helper T cells: A new player in immune tolerance |
栗占国 | 北京大学人民医院 | Human Umbilical Cord Mesenchymal stem cells confer potent immunosuppressive effects in RA |